Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iSpecimen (ISPC) Non Operating Income (2020 - 2025)

Historic Non Operating Income for iSpecimen (ISPC) over the last 6 years, with Q3 2025 value amounting to $49574.0.

  • iSpecimen's Non Operating Income fell 8175.28% to $49574.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year decrease of 2900.36%. This contributed to the annual value of $1.5 million for FY2024, which is 775.39% down from last year.
  • According to the latest figures from Q3 2025, iSpecimen's Non Operating Income is $49574.0, which was down 8175.28% from $774183.0 recorded in Q2 2025.
  • iSpecimen's 5-year Non Operating Income high stood at $1.3 million for Q4 2023, and its period low was -$3.0 million during Q1 2021.
  • Moreover, its 5-year median value for Non Operating Income was $78209.0 (2023), whereas its average is $37683.8.
  • As far as peak fluctuations go, iSpecimen's Non Operating Income crashed by 11631.68% in 2022, and later soared by 756155.21% in 2023.
  • Over the past 5 years, iSpecimen's Non Operating Income (Quarter) stood at -$55389.0 in 2021, then skyrocketed by 67.41% to -$18053.0 in 2022, then surged by 7561.55% to $1.3 million in 2023, then tumbled by 65.21% to $468625.0 in 2024, then plummeted by 89.42% to $49574.0 in 2025.
  • Its Non Operating Income was $49574.0 in Q3 2025, compared to $774183.0 in Q2 2025 and $177649.0 in Q1 2025.